A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 14, 2023

Primary Completion Date

December 19, 2024

Study Completion Date

March 10, 2025

Conditions
Central Precocious Puberty
Interventions
DRUG

Leuprorelin Acetate Depot 3M

Leuprorelin Acetate Depot 3M SC injections.

Trial Locations (5)

100033

Beijing Children's Hospital, Capital Medical University, Beijing

200062

Shanghai Children's Hospital, Shanghai

250021

Provincial Hospital Affiliated to Shandong First Medical University, Jinan

430030

The Hospital attached by the Torigji Medical College, Huazhong Science and Technology University., Wuhan

510062

the First A liated Hospital of Sun Yat-sen University, Guangzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY